Dean Investment Associates’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-2,555
Closed -$1.38M – 208
2023
Q2
$1.38M Sell
2,555
-66
-3% -$36.1K 0.23% 166
2023
Q1
$1.41M Buy
2,621
+64
+3% +$32.6K 0.23% 155
2022
Q4
$1.31M Sell
2,557
-195
-7% -$94.9K 0.22% 159
2022
Q3
$1.2M Sell
2,752
-52
-2% -$25K 0.24% 156
2022
Q2
$1.32M Sell
2,804
-72
-3% -$35.1K 0.26% 159
2022
Q1
$1.46M Buy
2,876
+84
+3% +$40.3K 0.26% 147
2021
Q4
$1.48M Buy
+2,792
New +$1.34M 0.26% 159

Other funds holding CHE

Dean Investment Associates's CHE Position: Q3 2023 in Review

Dean Investment Associates sold out of Chemed (CHE) in Q3 2023, closing a stake of 2,555 shares — an estimated $1.38M sold.

Dean Investment Associates first reported a position in CHE in Q4 2021 and held it in 7 quarters. The position peaked at $1.48M in Q4 2021. 457 funds tracked by Wall St. Rank hold CHE as of Q3 2023.

  • Dean Investment Associates reported no remaining Chemed position as of Q3 2023 after selling out during the quarter.
  • Dean Investment Associates sold 2,555 Chemed shares in Q3 2023, an estimated $1.38M.
  • Dean Investment Associates first reported a position in Chemed in Q4 2021 and held it in 7 quarters.
  • Dean Investment Associates's Chemed position peaked at $1.48M in Q4 2021.
  • 457 funds tracked by Wall St. Rank held Chemed as of Q3 2023.

Based on Dean Investment Associates's 13F filing for Q3 2023, filed 13 Nov 2023.